Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome (Q33724041)

28 July 2017

title

Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome (English)

1 reference

28 July 2017

1 reference

Alberto Piperno

7

0 references

Tomas Ganz

object named as

Tomas Ganz

6

0 references

author name string

Paola Trombini

1

1 reference

28 July 2017

Valentina Paolini

2

1 reference

28 July 2017

Sara Pelucchi

3

1 reference

28 July 2017

Raffaella Mariani

4

1 reference

28 July 2017

Elizabeta Nemeth

5

1 reference

28 July 2017

publication date

18 April 2011

1 reference

28 July 2017

1 reference

28 July 2017

volume

31

1 reference

28 July 2017

issue

7

1 reference

28 July 2017

page(s)

994-1000

1 reference

Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD).

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Hepcidin modulation in human diseases: from research to clinic.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Hemochromatosis: an endocrine liver disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Fatty liver: a novel component of the metabolic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

The assessment of insulin resistance in man.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Insulin resistance-associated hepatic iron overload.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Regulators of iron balance in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4048852

Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis

21 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02520.X

Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02520.X

Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02520.X

Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02520.X

Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons

21 January 2018

1 reference

12 December 2020

Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels

1 reference

12 December 2020

The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients

1 reference

12 December 2020

Dysmetabolic iron overload syndrome

1 reference

12 December 2020

Prevalence of body iron excess in the metabolic syndrome

1 reference

12 December 2020

The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH

1 reference

12 December 2020

10.1111/J.1478-3231.2011.02520.X

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference